Articles

CDMO will be providing high-quality lentiviral vectors for CAR-T therapies.




Vector BioMed Makes Company Debut

Location serves as the US flagship for company’s global pharma development network.  




In effort to preserve medication, contribution will provide 150 refrigeration units across 17 countries. 




The latest people news happenings over the past month.

Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.



Citing FDA’s slow guidance, the American Pharmacists Association is requesting delay in November 2023 DSCSA enforcement.



Complex to develop cGMP-compliant, commercial-scale plasmid DNA. 



Companies to release variety of options for this sector.

 


Platform expected to allow customers to meet various logistics requirements, company says.



Expansion expected to help tackle health issues at a faster rate, company says


